The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor,NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy Julie Litz, Elisabeth Buchdunger, et al. Clin Cancer Res 2005;11:1563-1571
The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571,delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling Julie Litz, Elisabeth Buchdunger, et al Mol Cancer Ther 2004;3:527-536
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.